Changchun BCHT Biotechnology Co. (SHA:688276)
China · Delayed Price · Currency is CNY 19.65
+0.13 (0.67%)
Feb 24, 2026, 3:00 PM CST
SHA:688276 Revenue
Changchun BCHT Biotechnology Co. had revenue of 189.55M CNY in the quarter ending September 30, 2025, a decrease of -53.50%. This brings the company's revenue in the last twelve months to 677.51M, down -57.85% year-over-year. In the year 2024, Changchun BCHT Biotechnology Co. had annual revenue of 1.23B, down -32.64%.
Revenue (ttm)
677.51M
Revenue Growth
-57.85%
P/S Ratio
12.00
Revenue / Employee
531.80K
Employees
1,266
Market Cap
8.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.23B | -595.60M | -32.64% |
| Dec 31, 2023 | 1.82B | 753.24M | 70.30% |
| Dec 31, 2022 | 1.07B | -130.58M | -10.86% |
| Dec 31, 2021 | 1.20B | -239.33M | -16.60% |
| Dec 31, 2020 | 1.44B | 465.69M | 47.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Animal Husbandry Industry | 6.28B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Cisen Pharmaceutical | 3.56B |
| Jiangsu Kanion Pharmaceutical | 3.13B |
| Guangxi Wuzhou Zhongheng Group | 2.29B |
| Sunflower Pharmaceutical Group Co.,Ltd | 2.09B |
| Hubei Hongyuan Pharmaceutical Technology | 1.77B |
| Sichuan Huiyu Pharmaceutical | 984.29M |